Takeda Posts Lower Nine-Month Revenue but Higher Profit, Lifts Dividend and Trims Growth Outlook

Takeda Pharmaceutical Co ( (JP:4502) ) has shared an update.

Takeda reported a 3.3% year-on-year decline in revenue to ¥3.41 trillion for the nine months ended December 31, 2025, while operating profit edged up 1.2% and net profit attributable to owners rose 2.4% to ¥216.1 billion, supported by higher profit before tax and a sharp increase in total comprehensive income. Core operating profit fell 3.4%, and Core EPS declined to ¥428, but the company’s equity position strengthened, with total assets and equity attributable to owners increasing and the equity ratio improving to 49.6%, alongside a planned dividend increase to a full-year total of ¥200 per share for the fiscal year ending March 31, 2026.

For the full fiscal year ending March 31, 2026, Takeda now forecasts a modest 1.1% decline in both reported and Core revenue to ¥4.53 trillion but expects operating profit to grow 19.7% and net profit attributable to owners to jump 42.7%, with Core operating profit and Core EPS both projected to decline slightly. Management has revised its guidance to indicate low-single-digit declines in Core revenue, Core operating profit and Core EPS on a constant exchange rate basis, signaling a near-term focus on profit resilience and shareholder returns in a challenging revenue environment.

The most recent analyst rating on (JP:4502) stock is a Hold with a Yen5496.00 price target. To see the full list of analyst forecasts on Takeda Pharmaceutical Co stock, see the JP:4502 Stock Forecast page.

More about Takeda Pharmaceutical Co

Takeda Pharmaceutical Company Limited is a Japan-based global biopharmaceutical company listed on the Tokyo, Nagoya, Sapporo and Fukuoka stock exchanges. It focuses on researching, developing and commercializing prescription medicines across key therapeutic areas, and reports its financials under IFRS with an emphasis on both IFRS and non-IFRS (Core) performance measures for investors.

Average Trading Volume: 4,842,472

Technical Sentiment Signal: Buy

Current Market Cap: Yen8065.9B

See more insights into 4502 stock on TipRanks’ Stock Analysis page.